Impact of thalidomide-based induction regimens on PBSC harvest in multiple myeloma patients

被引：0
|
作者：
Lanska, M. [1 ]
Maisnar, V. [1 ]
Radocha, J. [1 ]
Zak, P. [1 ]
Zavrelova, A. [1 ]
Blaha, M. [1 ]
Horacek, J. [1 ]
Doskocilova, K. [1 ]
Maly, J. [1 ]
机构：
[1] Teaching Hosp, Hradec Kralove, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [1] Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression
    Sung-Hoon Jung
    Hyun-Jung Choi
    Myung-Geun Shin
    Seung-Shin Lee
    Eu Chang Hwang
    Tae-Young Jung
    Min-Seok Cho
    Deok-Hwan Yang
    Jae-Sook Ahn
    Yeo-Kyeoung Kim
    Hyeoung-Joon Kim
    Je-Jung Lee
    Annals of Hematology, 2016, 95 : 1645 - 1651
  • [2] Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression
    Jung, Sung-Hoon
    Choi, Hyun-Jung
    Shin, Myung-Geun
    Lee, Seung-Shin
    Hwang, Eu Chang
    Jung, Tae-Young
    Cho, Min-Seok
    Yang, Deok-Hwan
    Ahn, Jae-Sook
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    ANNALS OF HEMATOLOGY, 2016, 95 (10) : 1645 - 1651
  • [3] Treatment for patients with multiple myeloma complicated by renal failure by thalidomide-based regimens
    Seol, Y.
    Chung, J.
    Kwon, B.
    Song, M.
    Choi, Y.
    Shin, H.
    Kim, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Discordant response or progression in patients with myeloma treated with thalidomide-based regimens
    Anagnostopoulos, A
    Hamilos, G
    Zorzou, MP
    Grigoraki, V
    Anagnostou, D
    Dimopoulos, MA
    LEUKEMIA & LYMPHOMA, 2004, 45 (01) : 113 - 116
  • [5] Thalidomide-based Regimens for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-analysis
    Lyu, Wen-Wen
    Zhao, Qing-Chun
    Song, De-Hai
    Zhang, Jin-Jie
    Ding, Zhao-Xing
    Li, Bao-Yuan
    Wei, Chuan-Mei
    CHINESE MEDICAL JOURNAL, 2016, 129 (03) : 320 - 325
  • [6] Thalidomide-based Regimens for Elderly and/or Transplant Ineligible Patients with Multiple Myeloma: A Meta-analysis
    Lyu Wen-Wen
    Zhao Qing-Chun
    Song De-Hai
    Zhang Jin-Jie
    Ding Zhao-Xing
    Li Bao-Yuan
    Wei Chuan-Mei
    中华医学杂志英文版, 2016, 129 (03) : 320 - 325
  • [7] Treatment of relapsed/refractory multiple myeloma with thalidomide-based regimens: Identification of prognostic factors
    Anagnostopoulos, A
    Gika, D
    Hamilos, G
    Zervas, K
    Zomas, A
    Pouli, A
    Zorzou, M
    Kastritis, E
    Anagnostopoulos, N
    Tassidou, A
    Anagnostou, D
    Dimopoulos, MA
    LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2275 - 2279
  • [8] The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicenter Analysis
    Lu, Jing
    Lu, Jin
    Liu, Aijun
    Fu, Weijun
    Du, Juan
    Huang, Xiaojun
    Chen, Wenming
    Hou, Jian
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [9] EFFICACY OF THALIDOMIDE-BASED AND BORTEZOMIB-BASED REGIMENS IN THE FIRST RELAPSE OF 146 MULTIPLE MYELOMA PATIENTS: A SINGLE CENTRE EXPERIENCE
    Krejci, M.
    Adam, Z.
    Krivanova, A.
    Pour, L.
    Zahradova, L.
    Mayer, J.
    Vorlicek, J.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 575 - 575
  • [10] VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens
    L Lopes-Aguiar
    M T Delamain
    A B C Brito
    G J Lourenço
    E F D Costa
    G B Oliveira
    J Vassallo
    C A De Souza
    C S P Lima
    Blood Cancer Journal, 2017, 7 : e580 - e580
12345